http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2023295181-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0b09584fcdc1896646c7d1863a083d1f
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2300-00
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D498-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-554
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D513-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D487-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D487-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-475
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D487-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D498-04
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D487-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D513-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D487-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D498-04
filingDate 2021-04-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1a2aed6b4e209892cf841fdb054279b0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9e5e993f9bab75833e456df1c3eec539
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_36ce564ea8218979e7d1aaa0d15e96a0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_470a1b8adaa8beae44532a2b270daafb
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1997b93789da0f49fcbb948dfd87029a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d039ea54a6accde818204ab40f3cd892
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d72343338f83a51a82d3cc58eb7d005f
publicationDate 2023-09-21-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber US-2023295181-A1
titleOfInvention Inhibitor of apoptosis (iap) protein antagonists
abstract Provided herein are compounds that modulate the activity of melanoma inhibitor of apoptosis (ML-IAP) protein, compositions comprising the compounds, and methods of using the compounds and compositions comprising the compounds.
priorityDate 2020-04-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID157035367
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID485227424
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID129903791
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID129903790
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID157035234
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID485227440
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID169057981
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID485227436
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID485227439
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID485227419

Total number of triples: 40.